TransMedics (TMDX) Short-term Investments (2019 - 2022)

TransMedics has reported Short-term Investments for 4 years, with the latest figure at $27.7 million in Q2 2022.

• On a quarterly basis, Short-term Investments fell 68.14% year-over-year to $27.7 million in Q2 2022; TTM through Jun 2022 was $27.7 million, a 68.14% decrease from a year earlier, with the FY2021 full-year figure at $66.9 million, down 33.83% from the prior year.
• Short-term Investments was $27.7 million for Q2 2022 at TransMedics, down from $54.1 million in the prior quarter.
• The five-year high for Short-term Investments was $111.3 million in Q3 2020, with the low at $27.7 million in Q2 2022.
• Average Short-term Investments over 4 years is $70.4 million, with a median of $67.4 million recorded in 2019.
• The sharpest annual moves came in 2021 and 2022: Short-term Investments soared 91.12% in 2021, then tumbled 68.14% in 2022.
• Over 4 years, Short-term Investments stood at $60.6 million in 2019, then jumped by 66.78% to $101.1 million in 2020, then sank by 33.83% to $66.9 million in 2021, then plunged by 58.58% to $27.7 million in 2022.
• The last three Short-term Investments figures came in at $27.7 million (Q2 2022), $54.1 million (Q1 2022), and $66.9 million (Q4 2021), per Business Quant data.